Barely Significant
← all excerpts

Add-on sirolimus for the treatment of mild or moderate systemic lupus erythematosus via T lymphocyte subsets balance.

Lupus Sci Med · 2024 · PMC10868177 · PMID 38351097

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
After treatment with sirolimus, with the increase in the number of Th2 cells, the Th1/Th2 balance in patients gradually showed a trend of being dominated by Th2.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.